Related Experiment Video

Updated: Mar 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil

Hiroshi Sakata1, Haruo Kuroki2, Kazunobu Ouchi3

  • 1Department of Pediatrics, Asahikawa Kosei Hospital, Japan.

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|February 28, 2017
PubMed

Insights

A 3-day course of tebipenem pivoxil effectively treated pediatric community-acquired pneumonia, showing significant fever reduction and improved inflammatory markers. This antibiotic regimen proved safe, with only mild diarrhea reported in a few patients.

Area of Science:

  • Pediatric infectious diseases
  • Pharmacology
  • Clinical microbiology

Background:

  • Community-acquired pneumonia (CAP) is a common pediatric illness.
  • Optimizing antibiotic treatment duration is crucial for efficacy and reducing resistance.
  • Tebipenem pivoxil is an oral carbapenem with potential for treating bacterial infections.

Purpose of the Study:

  • To evaluate the efficacy and safety of a short-course (3-day) tebipenem pivoxil regimen for pediatric CAP.
  • To assess clinical and laboratory markers of treatment response.

Main Methods:

  • A prospective study involving 49 pediatric patients diagnosed with CAP.
  • Tebipenem pivoxil administered for 3 days.
  • Effectiveness evaluated based on clinical cure, temperature, leukocyte counts, and C-reactive protein levels.

Main Results:

  • Clinical cure observed in 32 out of 36 evaluated patients (7-15 days post-treatment).
  • Significant reduction in body temperature within 24 hours of treatment initiation (median 38.8°C to 37.0°C).
  • Significant decrease in leukocyte counts and C-reactive protein levels by Days 2-4.
  • Six patients (12.2%) experienced mild diarrhea; no other significant adverse events reported.

Conclusions:

  • A 3-day treatment regimen of tebipenem pivoxil is safe and efficacious for pediatric community-acquired pneumonia.
  • Short-course therapy demonstrates rapid clinical and laboratory improvements.
  • Tebipenem pivoxil offers a promising option for outpatient management of pediatric CAP.
Keywords:
Community-acquired pneumoniaPediatricTebipenem pivoxil

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
976
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
588
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
545